Hologic hopes to become best in breast care market with $240m Suros buy
This article was originally published in Clinica
Executive Summary
In a bid to strengthen its presence in the women's health market, mammography systems manufacturer Hologic has agreed to acquire Suros Surgical Systems, the number two player in the US vacuum-assisted breast biopsy devices market, in a transaction valued at $240m. The acquisition is expected to close by the end of June, whereby Suros will become a wholly-owned subsidiary of Hologic.